Delhi LG Recommends Fresh CBI Probe Into 'Fake Lab Tests On Ghost Patients' In Mohalla Clinics

Delhi LG recommended a probe by CBI into the allegations of fake lab tests on ghost patients in mohalla clinics.

Delhi LG recommeds CBI probe into fake lab tests in mohalla clinics

Source : Getty Images

Delhi Lieutenant Governor VK Saxena has recommended a probe by the Central Investigation Bureau into the allegations of fake lab tests on ghost patients in mohalla clinics run by the Delhi government. Allegation has been made that lakhs of tests were done on ghost patients to help private labs as payments were made against those tests. 

As per ABP News sources, the scam is said to run in crores of Rupees at the cost of poor people. 

Doctors at mohalla clinics marked attendance through pre-recorded videos and unauthorised /non-medical staff prescribed tests and medicines to patients, the sources added. 

The development comes days after a CBI probe was ordered by Saxena into the alleged supply of drugs to Delhi government hospitals that had failed "quality standard tests".

"Last year, it emerged that doctors were not coming to mohalla clinics but were still shown as present. It was found that despite their absence, tests and medicines were being prescribed. Later, it was found that tests were conducted on ghost patients. Following this, a CBI probe has been ordered," reported PTI quoting a source as saying.

Last month, Delhi LG had recommended a CBI probe into an alleged supply of drugs that failed quality standard tests in government hospitals. It was alleged that the drugs have the “potential of endangering lives.” 

"It is with a sense of deep concern that I have perused the file. I am, to say the least, anguished at the fact that lakhs of hapless people and patients are being supplied fake drugs that have failed quality standard tests," Saxena wrote in a letter to Chief Secretary Naresh Kumar flagging his concern. 

"Tested by government as well as private analysts/ laboratories as per rules and statutory provisions under the Drugs and Cosmetics Act, 1940, these have failed and are categorised as ‘Not of Standard Quality’," he further wrote.